These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 2789405

  • 1. The effects on central dopamine function of chronic L-dopa (methyl ester hydrochloride) treatment of mice.
    Tabar J, Hashizume M, Cook CJ, Beart PM, Jackson DM.
    Pharmacol Biochem Behav; 1989 May; 33(1):139-46. PubMed ID: 2789405
    [Abstract] [Full Text] [Related]

  • 2. Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF38393.
    Jackson DM, Hashizume M.
    Psychopharmacology (Berl); 1986 May; 90(1):147-9. PubMed ID: 3094056
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of dopamine agonists in mature and immature rats.
    McDevitt JT, Setler PE.
    Eur J Pharmacol; 1981 Jun 10; 72(1):69-75. PubMed ID: 6973482
    [Abstract] [Full Text] [Related]

  • 4. Enhancement by a single dose of reserpine (plus alpha methyl-p-tyrosine) of the central stimulatory effects evoked by dopamine D-1 and D-2 agonists in the mouse.
    Ross SB, Jackson DM, Wallis EM, Edwards SR.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 May 10; 337(5):512-8. PubMed ID: 3261844
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Further studies on the interaction between bromocriptine and SKF38393 in reserpine and alpha methyl-para-tyrosine-treated mice.
    Jackson DM, Ross SB, Hashizume M.
    Psychopharmacology (Berl); 1988 May 10; 94(3):321-7. PubMed ID: 2895938
    [Abstract] [Full Text] [Related]

  • 9. Receptor changes during chronic dopaminergic stimulation.
    Jenner P, Boyce S, Marsden CD.
    J Neural Transm Suppl; 1988 May 10; 27():161-75. PubMed ID: 2900291
    [Abstract] [Full Text] [Related]

  • 10. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
    Hall MD, Cooper DR, Fleminger S, Rupniak NM, Jenner P, Marsden CD.
    Neuropharmacology; 1984 May 10; 23(5):545-53. PubMed ID: 6539859
    [Abstract] [Full Text] [Related]

  • 11. Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys.
    Falardeau P, Bouchard S, Bédard PJ, Boucher R, Di Paolo T.
    Eur J Pharmacol; 1988 May 20; 150(1-2):59-66. PubMed ID: 3261249
    [Abstract] [Full Text] [Related]

  • 12. Chronic L-DOPA treatment of mice: a behavioural and biochemical study.
    Bailey R, Crisp E, Jackson DM, Jenkins O.
    J Neural Transm; 1981 May 20; 50(2-4):209-24. PubMed ID: 6787171
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Climbing and stereotyped behaviours in mice require the stimulation of D-1 dopamine receptors.
    Vasse M, Chagraoui A, Protais P.
    Eur J Pharmacol; 1988 Mar 29; 148(2):221-9. PubMed ID: 2897924
    [Abstract] [Full Text] [Related]

  • 16. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
    Fletcher GH, Starr MS.
    Neuroscience; 1987 Dec 29; 23(3):1001-10. PubMed ID: 2963970
    [Abstract] [Full Text] [Related]

  • 17. The role of multiple dopamine receptors in apomorphine and N-n-propylnorapomorphine-induced climbing and hypothermia.
    Moore NA, Axton MS.
    Eur J Pharmacol; 1990 Mar 20; 178(2):195-201. PubMed ID: 2184043
    [Abstract] [Full Text] [Related]

  • 18. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ, Albers LJ, Le H, Creese I.
    J Pharmacol Exp Ther; 1986 Sep 20; 238(3):846-54. PubMed ID: 3018223
    [Abstract] [Full Text] [Related]

  • 19. The mode of action of bromocriptine following pretreatment with reserpine and alpha-methyl-p-tyrosine in rats.
    Ushijima I, Mizuki Y, Yamada M.
    Psychopharmacology (Berl); 1988 Sep 20; 95(1):29-33. PubMed ID: 2898789
    [Abstract] [Full Text] [Related]

  • 20. The effect of dopamine receptor agonist treatment on haloperidol-induced supersensitivity in mice.
    Fayle P, Jackson DM, Jenkins OF, Lafferty PA.
    Pharmacol Biochem Behav; 1985 Nov 20; 23(5):715-20. PubMed ID: 4080755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.